Trump Diagnosed with Common Vein Condition

White House: No Serious Health Concerns

Translate to Spanish or other 102 languages!

President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. Image for illustration purposes
President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. Image for illustration purposes
- Advertisement -

Mega Doctor News

President Donald Trump has been diagnosed with chronic venous insufficiency, a common vascular condition that affects blood flow in the legs. The announcement came Thursday, July 17, 2025, during a briefing by White House Press Secretary Karoline Leavitt.

“President Trump recently noticed mild swelling in his lower legs and sought medical evaluation out of an abundance of caution,” Leavitt stated. She explained that the former president underwent a series of vascular assessments, including Doppler ultrasounds, to determine the cause of the swelling.

- Advertisement -

The tests confirmed that Trump is experiencing chronic venous insufficiency, a condition in which the valves in the veins of the legs are unable to return blood efficiently to the heart, leading to fluid buildup and swelling. “This is a benign and manageable condition, frequently seen in older adults, particularly those over 70,” Leavitt said. “It is not life-threatening and does not impact his ability to travel, speak, or lead.”

According to the White House medical team, Trump’s diagnosis followed the exclusion of more serious conditions. “The president has tested negative for deep vein thrombosis, arterial disease, heart failure, and kidney dysfunction,” Leavitt reported. “His cardiovascular and renal health remain excellent.”

Chronic venous insufficiency affects approximately 5 percent of adults and is characterized by symptoms such as leg swelling, discoloration, and in some cases, skin ulcers. It is typically managed with compression garments, leg elevation, and lifestyle adjustments.

“President Trump is not experiencing discomfort and remains in excellent overall health,” Leavitt assured reporters. “His energy and daily activity level are unchanged, and he continues to fulfill his schedule without restriction.”

- Advertisement -

The announcement followed recent public speculation after photographs circulated online showing swelling in Trump’s lower legs during a campaign appearance. When asked about these concerns, Leavitt responded, “Out of transparency and care for public interest, we wanted to provide full clarity regarding the former president’s health.”

At this time, no additional medical interventions are planned beyond routine monitoring. “The president will continue to be evaluated regularly, as is standard for someone of his age and stature,” Leavitt added.

The White House emphasized that the condition poses no current health risk and does not interfere with Trump’s ongoing political activities.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Reveals Link Between Parent and Child Weight Is Mostly Genetic

The link between parents’ body mass index (BMI) and their children’s BMI in childhood is driven largely by genetic inheritance, rather than by any direct biological effects of parental weight during pregnancy, a new study suggests.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

The Genetic Armor Defeating Colorectal Cancer

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University, and institutions across the U.S., have published a landmark paper on the role of TGFBR1*6A, a naturally occurring genetic mutation in the TGFBR1 gene found in approximately 14 percent of the general population. Image for illustration purposes

Why CKM Syndrome Requires a Coordinated Care Point Person

When the term “cardiovascular-kidney-metabolic syndrome” was created in 2023 to define how heart disease, kidney disease, obesity and diabetes are connected, one goal was to help health professionals understand the benefits of working together.
- Advertisement -